0
0

Chapter 7. Hypnotics

DOI: 10.1176/appi.books.9781585624119.606852

Sections

Excerpt

Insomnia is generally defined as a difficulty initiating or maintaining sleep or a poor quality of sleep. Insomnia may be primary or secondary to other conditions such as depression, anxiety, mania, or substance abuse. Primary insomnia appears to be uncommon relative to secondary insomnia. Various population surveys have found self-reported rates of symptoms of insomnia in about a third of adults. About 10% of the U.S. population report having experienced symptoms of chronic insomnia that may have lasted for many years. However a smaller percentage of patients have insomnia with significant daytime impairment. According to the "NIH State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults Statement" (2005), perhaps 10% of the population has clinically significant insomnia if the criterion of daytime impairment is included in the criteria. Women and older adults appear to be the demographic groups at greatest risk for significant insomnia, but of course transient insomnia can affect anyone.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figure 7–1. Chemical structures of benzodiazepine hypnotics.

Figure 7–2. Chemical structures of the nonbenzodiazepine hypnotics zolpidem, zaleplon, and eszopiclone.

Figure 7–3. Chemical structures of nonbarbiturate hypnotics.
Table Reference Number
Table 7–1. Benzodiazepine hypnotics
Table Reference Number
Table 7–2. Barbiturates for insomnia
Table Reference Number
Table 7–3. Other nighttime hypnotic agents

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 13.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 16.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 42.  >
The American Psychiatric Publishing Textbook of Psychiatry, 6th Edition > Chapter 27.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 56.  >
Topic Collections
Psychiatric News
PubMed Articles
Anesthesia challenge in dental abscess induced trismus: a case report. Middle East J Anesthesiol 2014;22(4):437-40.
Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients. Z Gerontol Geriatr 2014;47(4):279-284.doi:10.1007/s00391-014-0654-5.
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation